Tips

ʮһÔÂ×ðÁú¿­Ê±½«Ö÷Àí2 ³¡ÏßÉÏÖ±²¥£¬Í¬Ê±¼ÓÈë5 ³¡º£ÄÚÍâÐÐÒµ¾Û»á£¬ÆÚ´ýÓëÁÐλҵÄÚͬÈʽ»Á÷·ÖÏíÒ©ÎïÑз¢ÐÂÇ÷ÊÆ¡£

15^th World ADC San Diego 2024

Antibody-drug conjugates are an important class of therapeutics for the treatment of cancer. ADCs are coming of age with a remarkable surge in recent times, that has marked a turning point in their development. 15^th World ADC San Diego 2024 is only one week to go!

We are excited to invite you to visit us at Medicilon Booth #512. Our Science and Business teams are looking forward to meeting you.

SITC 2024

Ready to Meet Medicilon at SITC's 39^th Annual Meeting & Pre-Conference Programs (SITC2024)? 

We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities. Cellular immunotherapy has developed by leaps and bounds in recent years, providing a cure for many difficult-to-treat cancers. Medicilon has built a one-stop service platform for the preclinical R&D of cellular immunotherapies, covering a variety of immunotherapy methods including CAR-T, TCR-T and CAR-NK. Using a wealth of animal models and a variety of advanced analysis techniques, comprehensively considering the characteristics of different research projects, Medicilon has completed numerous pre-clinical projects for clients worldwide.

Ê×½ìÁ¢ÒìÒ©Ñз¢ºÍ¶àά¶ÈÖÎÁÆÇ°ÑØ·å»á

2024Äê11ÔÂ9-10ÈÕ£¬ÓÉËÄ´¨´óѧ»ªÎ÷Ò½Ôº¡¢Öйúϸ°ûÉúÎïѧѧ»áÖ÷Àí£¬ÖйúÃâÒßѧ»á¡¢ËÄ´¨´óѧ»ªÎ÷Ò½ÔºÉúÎïÖÎÁÆÌìÏÂÖصãʵÑéÊÒ¡¢ËÄ´¨Ê¡¹ú¼Êҽѧ½»Á÷Ôö½ø»á¡¢ËÄ´¨´óѧ»ªÎ÷Ò½ÔºÃâÒßÑ×Ö¢Ñо¿ÔºÁªºÏÖ÷Àí£¬ËÕÖÝÊ¢½Ü¡¢GenEros Bio Pharma¡¢½¡Çź£³Ð°ìµÄ¡°Ê×½ìÁ¢ÒìÒ©Ñз¢ºÍ¶àά¶ÈÖÎÁÆÇ°ÑØ·å»áôßJAK-STATÐźÅͨ··¢Ã÷30ÖÜÄêÇìµä¡±½«Ôڳɶ¼¾ÙÐС£

×ðÁú¿­Ê±Ê×´´ÈË&CEO³Â´º÷벩ʿ½«·ÖÏí¡°Efficacy and Preclinical Research on JAK3 Inhibitor JANEX-1 for Treatment of Allergic Reaction and Asthma¡±£¡

×ðÁú¿­Ê±ÍŶӽ«ÔÚ1ºÅչλȫ³ÌÉèÕ¹£¡

µÚÊ®Æß½ì°ÙÊÀ»¯Ñ§ÖÆÒ©¹ú¼Ê´ó»áôßÕ¹ÀÀ»á

2024Äê11ÔÂ13-14ÈÕ£¬ÓÉ°ÙÊÀ´«Ã½Ö÷Àí£¬¹ã¶«Ò½¹È¡¢¹ã¶«Ê¡Ò©Ñ§»áÖÆÒ©¹¤³ÌרҵίԱ»á¡¢¹ã¶«Ê¡ÉúÎïÒ½Ò©Á¢ÒìÊÖÒÕЭ»á¡¢È«Çò¿µ½¡Ò©ÎïÑз¢ÖÐÐÄ¡¢ÁijǴóѧÉúÎïÖÆÒ©Ñо¿ÔºµÈÁªºÏÖ÷ÀíµÄ¡°CIS-Asia 2024 µÚÊ®Æß½ì°ÙÊÀ»¯Ñ§ÖÆÒ©¹ú¼Ê´ó»áôßÕ¹ÀÀ»á¡±½«ÔÚ¹ãÖݾÙÐС£

×ðÁú¿­Ê±»¯Ñ§²¿Ñз¢¸±×ܲÃÀîÖ¾¸Õ²©Ê¿½«·ÖÏí¡°ÒÔ°ÐÏòEGFRµÄPROTACÒ©ÎïÑз¢ÎªÀýµÄX-TACÑз¢Ë¼Ë÷¡±£¡

×ðÁú¿­Ê±ÍŶӽ«ÔÚ25ºÅչλȫ³ÌÉèÕ¹£¡

ACT 2024

American College of Toxicology (ACT) 2024 kicks off on November 17 2024 at JW Marriott Austin, Austin, Texas. Maybe we can work together and Medicilon can be a great partner! Come and chat with our American team at booth #117! Medicilon offers comprehensive toxicology study services designed to assess the safety profile and potential risks of pharmaceutical compounds. Our expert team collaborates closely with clients to tailor studies according to regulatory requirements and project-specific needs. Our state-of-the-art facilities, advanced platform, experienced scientists, and commitment to quality ensure that clients receive high quality, reliable, and regulatory-compliant GLP toxicology data to support the development of safe and effective pharmaceutical products. Medicilon has been at the forefront of pharmaceutical R&D for over 20 years. We have supported more than 2,000 global clients and have contributed to the IND approval of more than 490 drugs.

marketing@medicilon.com.cn
ýÌåÓë»áÎñÇëÁªÏµ
×ðÁú¿­Ê±Êг¡²¿Î¢ÐÅ»òÓÊÏä